LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 67.41 | 84.90 | 970 | 8766 | 0.1107 | 0.4392 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.11 | 84.90 | 1164 | 8988 | 0.1295 | 0.4759 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.11 | 84.90 | 1195 | 8988 | 0.1330 | 0.4817 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.11 | 84.90 | 455 | 8988 | 0.0506 | 0.2835 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 69.11 | 84.90 | 1148 | 8988 | 0.1277 | 0.4729 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.81 | 84.90 | 1160 | 9132 | 0.1270 | 0.4732 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.81 | 84.90 | 1191 | 9132 | 0.1304 | 0.4790 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.81 | 84.90 | 469 | 9132 | 0.0514 | 0.2882 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 70.81 | 84.90 | 1331 | 9132 | 0.1458 | 0.5035 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.52 | 84.90 | 1150 | 9214 | 0.1248 | 0.4702 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.52 | 84.90 | 1179 | 9214 | 0.1280 | 0.4756 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.52 | 84.90 | 465 | 9214 | 0.0505 | 0.2859 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 72.52 | 84.90 | 1029 | 9214 | 0.1117 | 0.4462 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.22 | 84.90 | 1160 | 9343 | 0.1242 | 0.4704 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.22 | 84.90 | 1189 | 9343 | 0.1273 | 0.4758 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.22 | 84.90 | 426 | 9343 | 0.0456 | 0.2685 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.22 | 84.90 | 950 | 9343 | 0.1017 | 0.4277 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 75.93 | 84.90 | 1164 | 8970 | 0.1298 | 0.4761 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 75.93 | 84.90 | 1199 | 8970 | 0.1337 | 0.4826 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 75.93 | 84.90 | 461 | 8970 | 0.0514 | 0.2862 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 75.93 | 84.90 | 1060 | 8970 | 0.1182 | 0.4557 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 77.64 | 84.90 | 1146 | 9245 | 0.1240 | 0.4690 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 77.64 | 84.90 | 1182 | 9245 | 0.1278 | 0.4758 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 77.64 | 84.90 | 431 | 9245 | 0.0466 | 0.2714 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 77.64 | 84.90 | 977 | 9245 | 0.1057 | 0.4348 | MN20160318_Q02 | M17 |